A detailed history of Mcdaniel Terry & CO transactions in Amgen Inc stock. As of the latest transaction made, Mcdaniel Terry & CO holds 1,042 shares of AMGN stock, worth $291,832. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,042
Previous 1,041 0.1%
Holding current value
$291,832
Previous $325,000 3.38%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $309 - $337
1 Added 0.1%
1,042 $336,000
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $19,706 - $23,948
-75 Reduced 6.72%
1,041 $325,000
Q1 2024

Apr 29, 2024

BUY
$268.87 - $324.56 $50,009 - $60,368
186 Added 20.0%
1,116 $317,000
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $237,801 - $268,267
930 New
930 $268,000
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $153,446 - $203,511
-842 Closed
0 $0
Q4 2019

Feb 03, 2020

BUY
$189.21 - $243.2 $159,314 - $204,774
842 New
842 $203,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mcdaniel Terry & CO Portfolio

Follow Mcdaniel Terry & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.